tiprankstipranks
22nd Century (XXII)
NASDAQ:XXII
US Market
Want to see XXII full AI Analyst Report?

22nd Century (XXII) Earnings Dates, Call Summary & Reports

1,805 Followers

Earnings Data

Report Date
Aug 19, 2026
After Close (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
Last Year’s EPS
-13.16
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:May 07, 2026|
% Change Since:
|
Earnings Call Sentiment|Neutral
The call conveyed cautious optimism: management reported clear early commercial progress with sequential revenue growth, gross loss improvement, strategic retail distribution wins, regulatory validation (FDA authorization) and a stable cash position. However, material challenges remain — operating losses and negative adjusted EBITDA widened, profitability is below targets, low-margin contracts persist, and retail adoption is uneven. Management plans focused investments in marketing and distribution with a target of ~5,000 outlets by year-end, but execution risk and competitive headwinds mean near-term results may continue to be pressured.
Company Guidance
The company guided to a 2026 execution-focused plan centered on scaling retail distribution and investing in consumer marketing, with specific near-term targets and metrics: Q1 2026 revenue was $4.1M (up ~16.1% sequentially from $3.5M in Q4 2025), gross loss improved to $0.6M (from $0.8M), operating loss and net loss were each $3.0M (vs. $2.8M), adjusted EBITDA was negative $2.6M (vs. negative $2.4M), and cash and equivalents stood at $9.5M; commercial targets include expanding to more than 5,000 retail outlets by year-end 2026, adding roughly 200 outlets in New York/New Jersey/Southern California in Q2/Q3, initial Southeast shipments in late Q3/early Q4, hiring a VP of Marketing and additional sales/marketing headcount, exiting low/no-margin contracts and prioritizing capital toward distribution growth, VLN commercial support, marketing initiatives and the reduced-nicotine pipeline, with the company expecting stronger commercial momentum in the back half of 2026.
Sequential Revenue Growth
Net revenue of $4.1M in Q1 2026, up from $3.5M in Q4 2025 — a sequential increase of approximately 16.1%.
Improved Gross Result
Gross loss narrowed to $0.6M from $0.8M in the prior quarter, a $0.2M improvement (about a 25% reduction in gross loss).
Distribution Wins and Retail Traction
Secured Pinnacle VLN distribution with the #3 U.S. tobacco purveyor (Pinnacle ranked #1 on sales per retail outlet for that retailer) and limited VLN distribution with the #2 purveyor in Illinois; plans to add ~200 outlets in NY/NJ/Southern California and additional Southeast distribution targeting ~5,000 retail outlets by end of 2026.
Regulatory and Scientific Validation
VLN is the only FDA-authorized cigarette of its kind and has recognition in WHO discussions and multiple scientific studies supporting the low nicotine approach, supporting competitive differentiation and regulatory alignment.
Strengthened Balance Sheet and Liquidity Management
Ended the quarter with $9.5M in cash and cash equivalents and management signaling disciplined capital allocation focused on commercial support, distribution growth and regulatory/product development.
Commercial and Marketing Investment Plan
Company is shifting to 100% execution and growth with plans to hire a VP of Marketing, invest in consumer marketing and merchandising, and exit low-margin contracts to improve gross profit mix over 2026.

22nd Century (XXII) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

XXII Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 19, 2026
2026 (Q2)
- / -
-13.16
May 07, 2026
2026 (Q1)
- / -5.07
-1.89-168.25% (-3.18)
Mar 26, 2026
2025 (Q4)
-2.10 / -5.89
-3653.5599.84% (+3647.66)
Nov 04, 2025
2025 (Q3)
-251.85 / -15.90
-12575.2599.87% (+12559.35)
Aug 14, 2025
2025 (Q2)
-93.15 / -13.16
-13972.599.91% (+13959.34)
May 13, 2025
2025 (Q1)
-379.50 / -1.89
-80109100.00% (+80107.11)
Mar 20, 2025
2024 (Q4)
- / -3653.55
-85698099.57% (+853326.45)
Nov 12, 2024
2024 (Q3)
- / -12575.25
-274233699.54% (+2729760.75)
Aug 13, 2024
2024 (Q2)
-231012.00 / -13972.50
-104328098.66% (+1029307.50)
May 15, 2024
2024 (Q1)
-245916.00 / -80109.00
-89424091.04% (+814131.00)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

XXII Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 07, 2026
$0.85$0.71-16.35%
Mar 26, 2026
$3.29$2.94-10.64%
Nov 04, 2025
$23.25$19.35-16.78%
Aug 14, 2025
$40.05$36.00-10.11%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does 22nd Century (XXII) report earnings?
22nd Century (XXII) is schdueled to report earning on Aug 19, 2026, After Close (Confirmed).
    What is 22nd Century (XXII) earnings time?
    22nd Century (XXII) earnings time is at Aug 19, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is XXII EPS forecast?
          Currently, no data Available